Pentwater Capital Management’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,000
| Closed | -$453K | – | 85 |
|
|
2023
Q2 | $453K | Sell |
25,000
-15,000
| -38% | -$272K | ﹤0.01% | 79 |
|
|
2023
Q1 | $1.06M | Buy |
+40,000
| New | +$1.06M | 0.01% | 75 |
|
|
2022
Q1 | – | Sell |
-60,000
| Closed | -$810K | – | 152 |
|
|
2021
Q4 | $810K | Hold |
60,000
| – | – | 0.01% | 138 |
|
|
2021
Q3 | $1.01M | Buy |
60,000
+30,000
| +100% | +$507K | 0.01% | 145 |
|
|
2021
Q2 | $874K | Hold |
30,000
| – | – | 0.01% | 181 |
|
|
2021
Q1 | $1.18M | Sell |
30,000
-10,500
| -26% | -$413K | 0.01% | 154 |
|
|
2020
Q4 | $920K | Hold |
40,500
| – | – | 0.01% | 127 |
|
|
2020
Q3 | $917K | Hold |
40,500
| – | – | 0.01% | 130 |
|
|
2020
Q2 | $1.32M | Buy |
+40,500
| New | +$1.32M | 0.02% | 68 |
|